Excipient Market Overview: Clariant sets up its first PEG excipients facility in US; India harmonizes 22 excipient monographs

DATA COMPILATION
#PharmaFlow

Pipeline Prospector March 2026 highlights: Lilly to acquire Centessa for US$ 7.8 bn; Merck buys Terns Pharma for US$ 6.7 bn

Stock Recap
#PipelineProspector

Diprosone

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

58 API Suppliers, 16 USDMF, 8 CEP/COS, 6 JDMF, 10 EU WC, 2 KDMF, 12 NDC API, 35 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

18 Drugs in Development

18 Drugs in Development

FINISHED DOSAGE FORMULATIONS

378 FDF Dossiers, 80 FDA Orange Book, 217 Europe, 3 Canada, 46 Australia, 9 South Africa, 23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT, AUGMENTED;TOPICAL - EQ 0.05% BASE, CREAM;TOPICAL - EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - EQ 0.05% BASE, OINTMENT;TOPICAL - EQ 0.05% BASE, CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, OINTMENT;TOPICAL - 0.064%;0.005%, SUSPENSION;TOPICAL - 0.064%;0.005%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc, 2 SPI Pharma, 1 Gangwal Healthcare, 7 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 1 Dr. Paul Lohmann GmbH & Co. KGaA, 1 Actylis, 11 BASF, 1 Clariant, 4 Corel Pharma Chem, 2 Finar, 4 Lubrizol Life Science Health, 11 Roquette, 1 Seppic, 2 Shandong Focus Biotechnology Co., Ltd, 1 Shijiazhuang Huaxu Pharmaceutical, 1 Valens Pharmachem, 1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

25 Topical, 13 Film Formers & Plasticizers, 9 Parenteral, 8 Emulsifying Agents, 6 Solubilizers, 6 Thickeners and Stabilizers, 4 Lubricants & Glidants, 4 Coating Systems & Additives, 4 Fillers, Diluents & Binders, 4 Taste Masking, 3 Direct Compression, 3 Surfactant & Foaming Agents, 2 Granulation, 2 Controlled & Modified Release, 2 Chewable & Orodispersible Aids, 1 Soft Gelatin, 1 Rheology Modifiers, 1 Co-Processed Excipients, 1 API Stability Enhancers

DIGITAL CONTENT

49 News #PharmaBuzz

49 News #PharmaBuzz

GLOBAL SALES INFORMATION

31 US Medicaid Prescriptions, 16 Regulatory FDF Prices, 16 Annual Reports

MARKET PLACE

23 APIs, 1 FDF Dossiers

PATENTS & EXCLUSIVITIES

21 US Patents, 6 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 5 Others

$ Xls download

Filters

Last Updated on PharmaCompass	Virtual Booth	Country	Registrant Name	MF Registration No.	Classification	Initial Date of Reg.	Latest Date of Reg.	Registrant's Address
31/03/2026	Curia	U.S.A	Curia Spain S. A. U.	219MF10367	Japanese Pharmacopoeia Betamethasone Dipropionate	2007-12-13	2017-12-08	Parque Tecnologico-Parcela 105 Boecillo (Valladolid) Spain
31/03/2026	MSD INTL GMBH	Singapore	MSD International GmbH (Singapore Branch)	218MF10865	Betamethasone dipropionate	2006-11-06	2014-03-13	50 Tuas West Drive Singapore 638408

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Diprosone

Diprosone

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

58 API Suppliers

16 USDMF

8 CEP/COS

6 JDMF

10 EU WC

2 KDMF

12 NDC API

35 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

18 Drugs in Development

FINISHED DOSAGE FORMULATIONS

378 FDF Dossiers

80 FDA Orange Book

217 Europe

3 Canada

46 Australia

9 South Africa

23 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

OINTMENT, AUGMENTED;TOPICAL - EQ 0.05% BASE

CREAM;TOPICAL - EQ 0.05% BASE;1% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - EQ 0.05% BASE

OINTMENT;TOPICAL - EQ 0.05% BASE

CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

OINTMENT;TOPICAL - 0.064%;0.005%

SUSPENSION;TOPICAL - 0.064%;0.005%

RELATED EXCIPIENT COMPANIES

1 Rochem International Inc

2 SPI Pharma

1 Gangwal Healthcare

7 Nanjing Well Pharmaceutical

3 Kirsch Pharma

1 Dr. Paul Lohmann GmbH & Co. KGaA

1 Actylis

11 BASF

1 Clariant

4 Corel Pharma Chem

2 Finar

4 Lubrizol Life Science Health

11 Roquette

1 Seppic

2 Shandong Focus Biotechnology Co., Ltd

1 Shijiazhuang Huaxu Pharmaceutical

1 Valens Pharmachem

1 Zhejiang Huakang Pharmaceutical

EXCIPIENTS BY APPLICATIONS

25 Topical

13 Film Formers & Plasticizers

9 Parenteral

8 Emulsifying Agents

6 Solubilizers

6 Thickeners and Stabilizers

4 Lubricants & Glidants

4 Coating Systems & Additives

4 Fillers, Diluents & Binders

4 Taste Masking

3 Direct Compression

3 Surfactant & Foaming Agents

2 Granulation

2 Controlled & Modified Release

2 Chewable & Orodispersible Aids

1 Soft Gelatin

1 Rheology Modifiers

1 Co-Processed Excipients

1 API Stability Enhancers

DIGITAL CONTENT

49 News #PharmaBuzz

GLOBAL SALES INFORMATION

31 US Medicaid Prescriptions

16 Regulatory FDF Prices

16 Annual Reports

MARKET PLACE

CREAM;TOPICAL - EQ 0.05% BASE;1% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

CREAM, AUGMENTED;TOPICAL - EQ 0.05% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

LOTION, AUGMENTED;TOPICAL - EQ 0.05% BASE Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons